Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Pepper Landson
Co-founder / CEO

Message the company or request a 1:1 meeting here

Praetego is a pre-clinical stage pharmaceutical company with a mission to improve the health and longevity of diabetic patients. Praetego is developing novel small molecules (Amadorins) to alleviate serious diabetic complications, starting with peripheral neuropathy. Amadorins are first-in-class molecules able to inhibit a primary driver of diabetic microvascular disease and are derived from a clinically proven prototype.

Executive Summary